2017
Overview
ABCB1 is a transmembrane protein that participates in drug transport and metabolism. Also known as P-glycoprotein, it is a member of the ATP-binding cassette (ABC) transporters that are widely distributed in tissues such as the liver, kidney, and intestine. ABCB1 plays an important role in maintaining the integrity of the blood-brain barrier, which is a critical determinant of central nervous system drug efficacy and toxicity. Furthermore, ABCB1 has been shown to modulate the pharmacokinetics of a broad range of drugs including anticancer agents, antifungal agents, and immunosuppressants by limiting their intracellular accumulation. Interestingly, recent studies have suggested a potential role for ABCB1 in the infection of the SARS-CoV-2 coronavirus. Through its interaction with the viral spike protein, ABCB1 might facilitate viral entry into host cells and promote the spread of the virus throughout the body. Given this potential involvement in the COVID-19 pandemic, ABCB1 is an essential target for future research in developing novel therapeutic strategies to combat this disease. In summary, ABCB1 is a critical protein with multidimensional functions in drug transport, pharmacokinetics, and the modulation of virus infection. With the current COVID-19 pandemic, it has become increasingly important to understand the molecular details of ABCB1 involvement in viral infection and exploit it as a new target for drug development to combat SARS-CoV-2.
Research published in this journal
2 peer-reviewed articles, ranked by relevance. Each links to its DOI.
2018
How this research is being cited
The 2 articles above have been cited 7 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2023 · Life
-
2023 · Life
-
2021 · Healthcare
-
2021 · Healthcare
-
2019 · Diagnosis
-
2019 · Diagnosis
-
2017 · Journal of Organ Transplantation
A sample of recent works citing this journal's research on ABCB1, linking to each citing work.